These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 34525965)
21. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota. Duytschaever G; Huys G; Bekaert M; Boulanger L; De Boeck K; Vandamme P J Cyst Fibros; 2013 May; 12(3):206-15. PubMed ID: 23151540 [TBL] [Abstract][Full Text] [Related]
22. What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics? van Dorst JM; Tam RY; Ooi CY Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276841 [TBL] [Abstract][Full Text] [Related]
23. A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics. Vernocchi P; Del Chierico F; Quagliariello A; Ercolini D; Lucidi V; Putignani L Nutrients; 2017 Dec; 9(12):. PubMed ID: 29232848 [TBL] [Abstract][Full Text] [Related]
26. Longitudinal analysis of fecal microbiome and metabolome during renal fibrotic progression in a unilateral ureteral obstruction animal model. Hu X; Xie Y; Xiao Y; Zeng W; Gong Z; Du J Eur J Pharmacol; 2020 Nov; 886():173555. PubMed ID: 32937112 [TBL] [Abstract][Full Text] [Related]
27. Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia. Lal CV; Kandasamy J; Dolma K; Ramani M; Kumar R; Wilson L; Aghai Z; Barnes S; Blalock JE; Gaggar A; Bhandari V; Ambalavanan N Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L810-L815. PubMed ID: 30113227 [TBL] [Abstract][Full Text] [Related]
28. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782 [TBL] [Abstract][Full Text] [Related]
29. Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis. Loman BR; Shrestha CL; Thompson R; Groner JA; Mejias A; Ruoff KL; O'Toole GA; Bailey MT; Kopp BT Pediatr Pulmonol; 2020 Jul; 55(7):1661-1670. PubMed ID: 32275127 [TBL] [Abstract][Full Text] [Related]
30. Multi-Compartment Profiling of Bacterial and Host Metabolites Identifies Intestinal Dysbiosis and Its Functional Consequences in the Critically Ill Child. Wijeyesekera A; Wagner J; De Goffau M; Thurston S; Rodrigues Sabino A; Zaher S; White D; Ridout J; Peters MJ; Ramnarayan P; Branco RG; Torok ME; Valla F; Meyer R; Klein N; Frost G; Parkhill J; Holmes E; Pathan N Crit Care Med; 2019 Sep; 47(9):e727-e734. PubMed ID: 31169619 [TBL] [Abstract][Full Text] [Related]
31. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis. Kummen M; Thingholm LB; Rühlemann MC; Holm K; Hansen SH; Moitinho-Silva L; Liwinski T; Zenouzi R; Storm-Larsen C; Midttun Ø; McCann A; Ueland PM; Høivik ML; Vesterhus M; Trøseid M; Laudes M; Lieb W; Karlsen TH; Bang C; Schramm C; Franke A; Hov JR Gastroenterology; 2021 Apr; 160(5):1784-1798.e0. PubMed ID: 33387530 [TBL] [Abstract][Full Text] [Related]
32. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill. Chen R; Wang J; Zhan R; Zhang L; Wang X J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318 [TBL] [Abstract][Full Text] [Related]
33. The Intestinal Microbiome and Cystic Fibrosis Transmembrane Conductance Regulator Modulators: Emerging Themes in the Management of Gastrointestinal Manifestations of Cystic Fibrosis. Karb DB; Cummings LC Curr Gastroenterol Rep; 2021 Aug; 23(10):17. PubMed ID: 34448955 [TBL] [Abstract][Full Text] [Related]
35. Adaptation of commensal proliferating Matamouros S; Hayden HS; Hager KR; Brittnacher MJ; Lachance K; Weiss EJ; Pope CE; Imhaus AF; McNally CP; Borenstein E; Hoffman LR; Miller SI Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1605-1610. PubMed ID: 29378945 [TBL] [Abstract][Full Text] [Related]
36. Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis. Debyser G; Mesuere B; Clement L; Van de Weygaert J; Van Hecke P; Duytschaever G; Aerts M; Dawyndt P; De Boeck K; Vandamme P; Devreese B J Cyst Fibros; 2016 Mar; 15(2):242-50. PubMed ID: 26330184 [TBL] [Abstract][Full Text] [Related]
37. Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health. Madan JC Clin Ther; 2016 Apr; 38(4):740-6. PubMed ID: 26973296 [TBL] [Abstract][Full Text] [Related]
38. CFTR dysregulation drives active selection of the gut microbiome. Meeker SM; Mears KS; Sangwan N; Brittnacher MJ; Weiss EJ; Treuting PM; Tolley N; Pope CE; Hager KR; Vo AT; Paik J; Frevert CW; Hayden HS; Hoffman LR; Miller SI; Hajjar AM PLoS Pathog; 2020 Jan; 16(1):e1008251. PubMed ID: 31961914 [TBL] [Abstract][Full Text] [Related]
39. Altered microbiota, fecal lactate, and fecal bile acids in dogs with gastrointestinal disease. Blake AB; Guard BC; Honneffer JB; Lidbury JA; Steiner JM; Suchodolski JS PLoS One; 2019; 14(10):e0224454. PubMed ID: 31671166 [TBL] [Abstract][Full Text] [Related]
40. Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome. Xi J; Ding D; Zhu H; Wang R; Su F; Wu W; Xiao Z; Liang X; Zhao Q; Hong Z; Fu H; Xiao Q BMC Microbiol; 2021 Aug; 21(1):226. PubMed ID: 34384375 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]